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Abstract
Phospholipase A2 (PLA2)-catalyzed hydrolysis of dipalmitoylphosphatidylcholine (DPPC) liposomes incorporated with
submicellar concentrations of polyethyleneoxide covalently attached to dipalmitoylphosphatidylethanolamine (DPPE-
PEG2000) has been studied in the gel-to-fluid transition region of the host DPPC lipid bilayer matrix. By means of
fluorescence and light-scattering measurements, the characteristic PLA2 lag time has been determined as a function of
lipopolymer concentration and temperature. The degree of lipid hydrolysis was followed using radioactive labeled lipids.
Differential scanning calorimetry has been applied to characterize the thermodynamic phase behavior of the lipopolymer-
containing liposomes. A remarkable lipopolymer concentration-dependent decrease in the lag time was observed over broad
temperature ranges. The radioactive measurements demonstrate an increase in catalytic activity for increasing amounts of
lipopolymers in the bilayer. Hence, the lipopolymers act as a promoter of PLA2 lipid hydrolysis resulting in a degradation of
the bilayer structure and a concomitant destabilization of the liposomes. This behavior is in contrast to the generally
observed protective and stabilization effect in biological fluids exerted by lipopolymers in polymer-grafted liposomes. It is
proposed that the enhanced activity of the small water soluble and interfacially active enzyme may involve a non-uniform
distribution of the lipopolymers in the lipid matrix due to a coupling between local lipid bilayer curvature and composition of
the non-bilayer-preferring lipopolymers. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Liposomes are potential candidates as microcarrier
systems for hydrophobic and hydrophilic drugs [1].
However, the utility of liposomes for delivering ther-
apeutic agents has been severely limited due to a
rapid removal and low circulation half-life, t1=2, on
the order of minutes in the blood stream [2,3]. An
improvement in the liposome survival time in the
blood stream to give t1=2 values on the order of hours
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Abbreviations: DPPC, dipalmitoylphosphatidylcholine; PLA2,
low molecular weight phospholipase A2 ; DPPE-PEG2000,
polyethyleneoxide-dipalmitoylphosphatidylethanolamine with 45
monomers; PA, palmitic acid; lysoPC, L-K-lysopalmitoylphos-
phatidylcholine; 14C-DPPC, 1-palmitoyl-2-[1-14C]palmitylphos-
phatidylcholine; DSC, di¡erential scanning calorimetry
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can be achieved by the use of small liposomes com-
posed of high-melting phospholipid bilayers incorpo-
rated with high amounts of cholesterol [4], e.g. lipid
bilayers in the so-called liquid-ordered phase charac-
terized by tightly packed and ordered lipid acyl
chains in a liquid-like bilayer matrix [5]. Both the
macroscopic phase behavior of liposomes as well as
the microscopic lipid bilayer organization are of im-
portance for the in vitro behavior and the in vivo
fate of liposomes, e.g. the long-term stability and
interaction of liposomes with biological components
as well as the distribution pro¢le in di¡erent tissues.
The prolongation of the circulation time of the lip-
osomes in the blood stream can be understood on
basis of an intimate relationship between the physi-
cochemical, mechanical, and functional properties
of lipid bilayers which are governed by the micro-
structural behavior of the composite lipid material
[3,6,7].
A signi¢cant increase in the circulation time in the
blood stream yielding t1=2 values on the order of
several hours can be obtained using surface-modi¢ed
liposomes incorporated with glycolipid gangliosides,
GM1 [8]. Moreover, incorporation of synthetic poly-
ethyleneoxide (PEG) lipopolymers into phospholipid
liposomes with mean diameters less than 100 nm
results in a further increase in the circulation time
and an improvement in the in vivo behavior [9]. Sur-
face-modi¢ed polyethyleneoxide liposomes better
known as sterically stabilized liposomes have come
into widespread use not only as particulate drug-de-
livery systems with improved therapeutic pro¢les
[10,11], but also as model systems to study surface
properties and phase behavior of polymer-grafted
liposomes [12^17].
Despite intensive research activities in the ¢eld of
sterically stabilized liposomes, the detailed mecha-
nisms involved in the increased circulation time in
the blood stream of PEG-grafted liposomes are still
not fully understood [18]. The stabilization and pro-
tective role induced by the lipopolymers is generally
considered to be the result of a steric barrier induced
by the £exible PEG chains [10,18]. The steric barrier
is believed to reduce the interactions between the
polymer-grafted bilayer surface and liposome-de-
grading biological components. Hence, the repulsive
interaction of the PEG polymer chains form a ster-
ic hindrance that prevents rapid recognition and
removal of the liposomes by phacocytic cells of
the reticoloendothelial system, RES [10,18]. It has
been shown that liposomes incorporated with lipo-
polymers bind less plasma proteins and that the
circulation time in the blood stream become short-
er, when more proteins are adsorbed to the surface
of the liposomes [9,19]. However, only a few
studies have dealt with the interaction of well-
de¢ned liposome systems with membrane active
and destabilization enzymes, such as phospholip-
ases.
To gain further insight into the molecular origin
and mechanisms underlying the prolongation of the
circulation time in the blood stream and the extra-
vascular degradation of polymer-grafted liposomes,
we have undertaken a systematic investigation of
the activity of PLA2-catalyzed phospholipid hydrol-
ysis of DPPC liposomes incorporated with DPPE-
PEG2000 lipopolymers. PLA2 belongs to a group of
structurally related membrane active enzymes which
are ubiquitously present in extra- and intracellular
compartments of human tissues and also constitute
the major component of several snake toxins [20,21].
The similarity of the amino acid sequences between
mammalian and snake venom PLA2 suggest com-
mon modes of lipid^membrane interactions and mo-
lecular mechanisms of the enzymatic phospholipid-
catalyzed hydrolysis at the lipid^membrane interface
[20,22]. PLA2-catalysis involves adsorption of the en-
zyme to the lipid^membrane interface followed by
hydrolysis of the phospholipids at the catalytic site
of the enzyme. It is well established that the catalytic
cleavage of phospholipids and the overall activity of
PLA2 depends strongly on the physical state and
microstructure of the lipid bilayer substrate. Es-
pecially, it has been shown that the activity of
PLA2 is signi¢cantly enhanced in the phospholipid
main-transition region where the activity correlates
strongly with the formation of a heterogeneous lat-
eral bilayer structure composed of coexisting dynam-
ic lipid domains, which in turn may increase PLA2-
catalyzed phospholipid cleavage [23^25]. In addition,
both the lateral surface stress and the incorporation
of non-bilayer forming lipids into the bilayer matrix
can give rise to an increase in the catalytic activity of
PLA2 [26,27].
Important drug-delivery aspects are related to an
improved understanding of the relevant barrier prop-
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erties of sterically stabilized liposomes that are in-
volved in the in vivo destabilization and interaction
of biological components with polymer-grafted lip-
osomes. Although intensive research studies have
been undertaken in the ¢eld of sterically stabilized
liposomes a detailed understanding of the mecha-
nisms that determine the in vivo destabilization and
clearance is still lacking.
In this study, we have investigated the activity of
PLA2 towards DPPC liposomes incorporated with
submicellar concentrations of DPPE-PEG2000 lipo-
polymers. The temperature dependence of the char-
acteristic lag time, denoting the time required before
a signi¢cant increase in the enzymatic activity takes
place, has been monitored as a function of lipopoly-
mer concentration of unilamellar extruded liposomes
in the temperature region of the main phase transi-
tion of the host DPPC lipid bilayer matrix. In addi-
tion, the degree of PLA2 catalyzed phospholipid hy-
drolysis has been followed after incorporation of
radioactive 14C-DPPC lipids into the lipid bilayer
matrix.
2. Materials and methods
2.1. Materials
Polyethyleneoxide DPPE-PEG2000 (MW of
PEG = 2053 g/mol, 45 monomers) lipopolymer and
saturated DPPC phospholipid were purchased as
powder from Avanti Polar Lipids (Birmingham,
AL, USA). Palmitic acid (PA) and L-K-lysopalmi-
toylphosphatidylcholine (lysoPC) were purchased
from Sigma (St. Louis, MO, USA). Radioactive-la-
beled DPPC (1-palmitoyl-2-[1-14C]palmityl-PC, 2.18
GBq/mmol) was from Amersham (Little Chalfont,
UK). Thin-layer chromatography plates (250-Wm
layer of Silica Gel 60) were from Merck (Damstadt,
Germany) and Ecoscient scintillation £uid was ob-
tained from National Diagnostics (Atlanta, GA,
USA).
2.2. Preparation of unilamellar liposomes
To form multilamellar liposomes, weighed
amounts of phospholipids and lipopolymers were
dissolved and mixed in chloroform. The organic sol-
vent was subsequently removed using a gentle stream
of clean air leaving a thin lipid ¢lm, which was dried
overnight at low pressure to remove any trace impur-
ities of the organic solvent. The multilamellar lipo-
somes were made by dispersion of the dried lipid in
bu¡er solution. The lipid suspension was kept for at
least 1 h at 51‡C to assure complete hydration. Dur-
ing this period, the lipid suspension was vortexed
several times. Unilamellar liposomes of narrow size
distribution were made from the multilamellar lipo-
somes by extrusion of the multilamellar samples ten
times through two stacked 100 nm pore size polycar-
bonate ¢lters [28].
2.3. Di¡erential scanning calorimetry and dynamic
light scattering
Di¡erential scanning calorimetry of 0.15 mM uni-
lamellar liposomes was performed using a MicroCal
MC-2 (Northhampton, MA) scanning calorimeter in
the upscan mode at a scan-rate of 10‡C/h. An appro-
priate baseline has been subtracted from the calori-
metric curves, whereas no correction was made for
the fast response time of the power-compensating
calorimeter. Size measurements of the unilamellar
liposomes were performed using a Zetasizer 4 (Mal-
vern, UK). The dynamic light scattering data were
collected at an angle of 90‡ using a helium laser as
light source. The liposomes were stored at 4‡C be-
tween the size measurements. The apparatus was
calibrated by measuring mono-dispersed polystyrene
latex-spheres of known size (220 nm).
2.4. PLA2 (Naja naja naja) radioactive phospholipid
hydrolysis
PLA2 (N. naja naja) for the radioactive phospho-
lipid hydrolysis measurements was purchased from
Sigma Chemical Co. and used without further puri-
¢cation. Assay conditions for the PLA2 radioactive
phospholipid hydrolysis included 2 mM unilamellar
liposomes, 0.49 WM PLA2, 10 mM CaCl2, 135 mM
KCl, 9 mM HEPES (pH 7.5), and 0.9 WM EDTA.
The catalytic reaction was initiated by adding 5 Wl of
a 49 WM PLA2 stock solution to 0.495 ml liposome
suspension thermostated at 41‡C. The concentration
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of radioactive-labeled 14C-DPPC lipid was 0.06
mol%. The enzymatic reaction was stopped after
20 min by the addition of 0.5 ml chloroform/meth-
anol/acetic acid (2:4:1 v/v/v). A 0.5 ml amount of
chloroform was added to extract the lipids to the
organic phase. The mixture was brie£y vortexed
and centrifuged to separate the organic and aqueous
phase. The organic layer was subsequently removed
and dried using a gentle stream of clean air. The lipid
extraction procedure was repeated three times. A 200
Wl amount of chloroform/methanol (1:1) was added
to dissolve the lipid residue. A 30 Wl amount of the
dissolved and hydrolyzed lipid sample was loaded
onto a thin-layer chromatography plate (one lane
of 2 cm width), and the lipids were separated over
16.5 cm by elution with chloroform/methanol/acetic
acid/water (25:15:4:2, v/v/v/v). The lipids were ex-
posed to I2 vapor, and the separated lipid zones
were scraped directly into scintillation vials into
which 3 ml of scintillation £uid was added. The
14C radioactivity was determined using a Minaxi
Tri-carb 4000 scintillator, United Technologies,
Packard.
2.5. PLA2 (Agkistrodon piscivoros piscivoros) lag
time measurements
Puri¢ed PLA2 (A. piscivoros piscivoros) for the lag
time measurements was a gift from Professor R.L.
Biltonen, University of Virginia. PLA2 has been iso-
lated and puri¢ed according to the procedure of
Maraganore et al. [29]. Assay conditions for the
PLA2 lag time measurements were 0.15 mM unila-
mellar liposomes, 150 nM PLA2, 150 mM KCl, 10
mM HEPES (pH 7.5), 1 mM NaN3, 30 WM CaCl2,
and 10 WM EDTA. The catalytic reaction was initi-
ated by adding 8.3 Wl of a 45 WM PLA2 stock sol-
ution to 2.5 ml of the thermostated lipid suspension
equilibrated for at least 20 min prior to addition of
the enzyme. The PLA2 reaction pro¢le and lag time
denoting the time required before the onset in rapid
enzymatic activity takes place, was de¢ned on basis
of a sudden increase in the intrinsic £uorescence
from PLA2 emitted at 340 nm after excitation at
285 nm and a decrease in 90‡ static light scattering
from the lipid suspension. The £uorescence and scat-
tering data were simultaneously measured using a
SLM DMX-1100 spectro£uorometer.
3. Results and discussion
3.1. Heat capacity and liposome size
Fig. 1 shows di¡erential scanning calorimetry re-
sults obtained at a scan rate of 20‡C/h for pure one-
component DPPC unilamellar liposomes and DPPC
liposomes incorporated with DPPE-PEG2000 lipo-
polymers in two di¡erent concentrations. The main
transition temperature, Tm, for pure DPPC unilamel-
lar liposomes takes place at 41.15‡C as determined
from the peak position of the heat capacity, Cp. The
minor peak on the upper temperature side of the
main peak re£ects a trace impurity of multilamellar
liposomes in the suspension. The Cp curves for the
unilamellar DPPC liposomes incorporated with 2.5
and 5 mol% DPPE-PEG2000 lipopolymer are only
weakly distorted as compared to the Cp curve for
pure 100 nm unilamellar DPPC liposomes. The
main transition temperature, Tm, de¢ned as the
peak maximum of the heat capacity curves in Fig.
1 is found to be rather insensitive to composition of
Fig. 1. Di¡erential scanning heat^capacity curves obtained at a
scan rate of 20‡C/h for DPPC unilamellar liposomes containing
0 mol% (solid line), 2.5 mol% (dotted line), and 5 mol%
(dashed line) DPPE-PEG2000 lipopolymers.
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the lipopolymer-containing liposomes. This behavior
is in accordance with thermodynamic data for 50 nm
extruded liposomes [17] and furthermore is to be ex-
pected when the lipopolymer concentration is below
the threshold concentration, ntr, for the lipid bilayer
to lipid micellar transition. Both theoretical and ex-
perimental investigations of mixed liposome systems
have estimated the micellar threshold value to be
around 10 mol% [13,14,17]. A change in the con¢g-
uration of the polymer chains from a so-called mush-
room to a brush structure is expected to take place
when the DPPE-PEG2000 concentration is increased
from 2.5 to 5 mol% [15,16].
Dynamic light scattering results of the time devel-
opment of the average particle size of extruded lip-
osomes is shown in Fig. 2 for di¡erent concentra-
tions of DPPE-PEG2000 lipopolymer in the lipid
bilayer. A signi¢cant increase in the characteristic
size of the pure DPPC liposomes takes place within
the ¢rst few days after extrusion possibly due to fu-
sion and a concomitant release of the curvature built
in stress of the extruded liposomes. This behavior is
opposite to DPPC liposomes incorporated with in-
creasing concentrations of DPPE-PEG2000 lipopoly-
mers. The presence of the lipopolymers in the bilayer
leads to a short-term as well as a long-term stabiliza-
tion of the size of the liposomes. The polymer-
grafted liposome surface forms a steric barrier that
prevent liposome^liposome contact which is a pre-
requisite for the formation of larger size liposomes
due to aggregation and/or fusion of the liposomes
[30]. Moreover, it is to be expected that the micel-
lar-preferring lipopolymers decrease the curvature
stress and thereby stabilize a smaller size of the ex-
truded liposomes.
3.2. PLA2 (N. naja naja) lipid hydrolysis
Fig. 3 shows the degree of PLA2 (N. naja naja)
lipid hydrolysis of the liposome suspensions 20 min
after addition of the enzyme as determined by radio-
active lipid measurements. A remarkably increase in
the degree of lipid hydrolysis takes place for increas-
ing concentrations of DPPE-PEG2000 in the lipo-
somes. When 7 mol% of DPPE-PEG2000 is incorpo-
rated into the lipid bilayer an almost complete PLA2-
catalyzed lipid hydrolysis of the liposomes takes
place. We shall below return to a more detailed dis-
cussion of the in£uence of DPPE-PEG2000 lipopoly-
mers on the enhancement of PLA2 activity which
might be closely related to the structural organiza-
tion of the lipopolymers in the bilayer matrix.
3.3. PLA2 (A. piscivorus piscivorus) lag time results
Typical PLA2 (A. piscivorus piscivorus) hydrolysis
time course pro¢les obtained at 39‡C are shown in
Fig. 4 for DPPC unilamellar liposomes incorporated
with 0, 2.5, and 5 mol% DPPE-PEG2000 lipopoly-
mers. The lag time, d, which is de¢ned on basis of
Fig. 2. Time development of the average particle size of DPPC
phospholipid liposomes containing 0 mol% (heavy solid line),
0.5 mol% (short dashed line), 2.5 mol% (dotted line), 5 mol%
(dashed line), and 7 mol% (thin solid line) DPPE-PEG2000 de-
termined by dynamic light scattering measurements.
Fig. 3. PLA2 (N. naja naja) hydrolysis of DPPE-PEG2000 lipo-
polymer-containing liposomes at 41‡C as determined by percent
of radioactive phospholipids (14C-DPPC) and fatty acids (14C-
PA) 20 min after adding the enzyme to the liposome suspen-
sion.
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a sudden increase in the rate of hydrolysis, is deter-
mined by a rapid increase in the intrinsic PLA2 tryp-
tophan £uorescence intensity [23,27,31] and a con-
comitant decrease in 90‡ static light scattering
caused by a change in the morphology of the lipid
system [24,25]. In Fig. 5, the lag time results are
shown as a function of temperature in the gel-to-£uid
transition of unilamellar liposomes composed of pure
DPPC, and for liposomes incorporated with 2.5 and
5 mol% DPPE-PEG2000 lipopolymer. Each of the
three lag time curves shown in Fig. 5 displays a mini-
mum in the temperature region of the gel-to-£uid
phase-transition temperature, Tm, as determined by
the Cp curves in Fig. 1. These minima become deeper
and broader for increasing concentrations of DPPE-
PEG2000 lipopolymer in the liposomes. It is well-
known that the lag time, d, for pure phospholipid
liposomes obtains a minimum at the gel-to-£uid tran-
sition, Tm, [24,32,33] possibly re£ecting the time re-
quired to accumulate a certain amount of hydrolysis
products in the lipid system [23,33]. The results
shown in Fig. 5 clearly reveal that a remarkably lipo-
polymer concentration-dependent lowering of d takes
place over broad temperature ranges in the transition
region. The signi¢cant e¡ect of DPPE-PEG2000 lipo-
polymers on the PLA2 lag time is further emphasized
by the data in Fig. 6, which shows the in£uence of
increasing lipopolymer concentrations at a ¢xed tem-
perature, T = 41‡C, corresponding to the minimum
value of d.
Fig. 4. Characteristic reaction time pro¢les at 39‡C for PLA2
(A. piscivorus piscivorus) hydrolysis of unilamellar DPPC lipo-
somes incorporated with 0, 2.5, and 5 mol% DPPE-PEG2000
lipopolymers. The PLA2 hydrolysis reaction is monitored by in-
trinsic £uorescence (solid line) from the enzyme and 90‡ static
light scattering (dashed line) from the suspension. After adding
PLA2 to the equilibrated liposome suspension a characteristic
lag time, d, follows before a sudden increase in the catalytic ac-
tivity of the enzyme takes place [23,24].
Fig. 5. PLA2 (A. piscivorus piscivorus) lag time, d, as a function
of temperature for the hydrolysis of DPPC liposomes incorpo-
rated with 0 mol% (solid line), 2.5 mol% (dotted line), and
5 mol% (dashed line) DPPE-PEG2000 lipopolymers.
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3.4. Modulation of PLA2 activity towards
polymer-grafted liposomes.
To provide a uni¢ed interpretation of the in£uence
of submicellar DPPE-PEG2000 lipopolymer concen-
trations on the activity of PLA2 in the temperature
region of the gel-to-£uid phase transition (cf. Fig. 3
and Fig. 5), we will make a simple assumption that
relates the lateral organization of the unhydrolyzed
lipid bilayer to the increase in PLA2 enzymatic activ-
ity. The existence of a heterogenous lipid bilayer
structure composed of lipid domains and interfacial
regions characterized by lipid packing defects have
been suggested to promote PLA2-catalyzed phospho-
lipid hydrolysis [26,32,34]. The incorporation of sub-
micellar lipopolymer concentrations into lipid bi-
layers is expected to give rise to the formation of
local phase-separated regions which are characterized
by a length scale in the nanometer range due to an
intimate relationship between composition and cur-
vature of the lipid matrix [35^37]. When low concen-
trations of DPPE-PEG2000 lipopolymers are incorpo-
rated into DPPC lipid bilayers the two components
are expected to be more or less uniformly distributed
in the lipid matrix due to the entropy of mixing. As
the lipopolymer concentration increases, a curvature
frustration is built up, where the two components
will compete for lipid bilayer regions of varying local
curvature [38]. Formation of lipid bilayer regions of
high curvature might therefore function as aggrega-
tion sites for the non-bilayer-preferring DPPE-
PEG2000 lipopolymers and furthermore give rise to
curvature induced phase-separation phenomena
[35,36]. This leads to a heterogeneous bilayer struc-
ture composed of coexisting lipid domains and inter-
facial regions with phospholipids which may exhibit
an increased susceptibility to PLA2-catalyzed hydrol-
ysis.
The formation of a heterogeneous lateral structure
and a network of interfacial regions with the lipo-
polymers segregated into regions of high curvature of
the undulating lipid bilayer might be an important
regulator of PLA2 activity. The results suggest that
submicellar lipopolymer concentrations act as a pro-
moter of PLA2 lipid hydrolysis resulting in a desta-
bilization of the bilayer structure by the hydrolysis
products and a concomitant degradation of the lip-
osomes. At this point in our investigation, however,
it is not clear if the non-bilayer-perturbing e¡ect of
DPPE-PEG2000 lowers the critical mole fraction of
hydrolysis of the lipid suspension [31] or simply ac-
celerates the process as suggested above. The ob-
served enhancement in catalytic activity (cf. Fig. 3
and Fig. 5) is opposite to the generally observed
protective and stabilizing e¡ect exerted by lipopoly-
mers in the blood stream, e.g., the lipopolymers es-
tablish a steric hindrance which leads to a decrease in
the adsorption and interaction of plasma degrading
proteins with the liposome surface [9,19]. An impor-
tant factor involved in destabilization of liposomes in
the blood stream is the physical adsorption of pro-
teins and enzymes to the liposome surface, e.g. trans-
fer of lipids by lipoproteins and the activity of lip-
olytic enzymes. However, the role of especially
phospholipases in the blood stream is considered to
be minimal [39] as suggested by the results reported
above. It is proposed that the enhanced in vitro cat-
alytic activity of the small water soluble and interfa-
cial active PLA2 enzyme observed in this work re-
£ects an intimate relationship between local lipid
bilayer curvature and composition of the non-bi-
layer-preferring lipopolymers. The formation of a
heterogeneous lateral bilayer structure composed of
lipid domains and interfacial regions with lipid pack-
ing defects may hence facilitate PLA2 lipid hydolysis
by making the interfacial phospholipids more acces-
Fig. 6. PLA2 (A. piscivorus piscivorus) lag time, d, as a function
of DPPE-PEG2000 lipopolymer concentration obtained at 41‡C.
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sible to the catalytic site of the enzyme. Other factors
which might contribute to the increased PLA2 hy-
drolysis towards PEG-containing liposomes com-
pared to pure DPPC liposomes involve di¡erences
in liposome size and lipid packing properties caused
by the incorporation of PEG-DPPE2000 lipids into
the bilayer matrix. It has been shown earlier that
the lag time of PLA2-catalyzed phospholipid hydrol-
ysis is directly proportional to the size of the lipo-
somes [40]. In addition, the hydrophilicity of the
lipopolymer network may cause a change in the af-
¢nity of the small water soluble PLA2 enzyme to the
polymer-grafted lipid bilayer surface, e.g. an increase
in the binding and contact time of the enzyme to the
liposomes.
The results presented above suggest that the en-
hanced catalytic hydrolysis of phospholipids by
PLA2 in polymer grafted liposomes is unlikely to
be involved in the prolonged circulation time in the
blood stream of sterically stabilized liposomes. In
contrast, an increase in the degradation of polymer
grafted liposomes in extravascular pathological tissue
is to be expected due to a combined e¡ect of an
elevated and high concentration of active PLA2
[41,42], and an increased catalytic activity towards
lipopolymer containing liposomes as suggested by
our results.
4. Conclusion
In this study, we have investigated the in£uence of
lipopolymer-containing liposomes on the activity of
PLA2. The results demonstrate an increase in the
susceptibility of the phospholipids to PLA2 catalytic
cleavage for increasing amounts of submicellar con-
centrations of lipopolymer in the lipid bilayer. It is
suggested that the enhanced enzymatic activity of
PLA2 is caused by a change in the microscopic lat-
eral organization of the lipid bilayer structure. In-
sight into microscopic and macroscopic bilayer prop-
erties that control the enzymatic phospholipid
hydrolysis and the overall destabilization of lipo-
somes plays a crucial role for the potential use of
liposomes as particulate drug-delivery systems [7].
In a broader context, the results presented above
may help clarifying the relationship between mem-
brane associated functions and structural properties
of lipid bilayers that are of signi¢cant basic and bio-
technological interest. A fundamental understanding
of the in£uence of composition on functional bioma-
terial properties of composite lipid systems are of
relevance for a rational modi¢cation and optimiza-
tion of liposomes as drug-carrier systems. The results
presented above might advantageously be used to
design and optimize the in vivo degradation of
drug loaded liposomes at certain sites, e.g. in ex-
travascular in£ammatory tissue due an enhanced lo-
cal concentration of active PLA2 and an accumula-
tion of polymer-grafted liposomes in such tissue. The
results may furthermore have implications for a
deeper understanding of the regulation of enzymatic
functions via modi¢cation of the physical properties
of the lipid bilayer component of biological mem-
branes [25,43].
Acknowledgements
This work was supported by the Danish Natural
Science and Technical Research Councils, the Carls-
berg Foundation, and the Danish Center for Drug
Design and Transport via the Danish Medical Re-
search Council. The Lundbeck Foundation is
thanked for an equipment grant. The authors grate-
fully acknowledge stimulating discussions and tech-
nical assistance from the MemPhys group at the
Technical University of Denmark. Professor Rodney
L. Biltonen, University of Virginia, is thanked for
providing puri¢ed PLA2 as a gift.
References
[1] D.D. Lasic, Liposomes: From Physics to Applications,
Elsevier, Amsterdam, 1993.
[2] R.M. Abra, C.A. Hunt, Liposome distribution in vivo: III
dose and vesicle size e¡ects, Biochim. Biophys. Acta 666
(1981) 493^503.
[3] J. Senior, Fate and behaviour of liposomes in vivo: a review
of controlling factors, CRC Crit. Rev. Ther. Drug. Carr.
Syst. 3 (1987) 123^193.
[4] J. Senior, J.C.W. Crawley, G. Gregoriadis, Tissue distribu-
tion of liposomes exhibiting long half-lives in the circulation
after intravenous injection, Biochim. Biophys. Acta 839
(1985) 1^8.
[5] J.H. Ipsen, O.G. Mouritsen, M. Bloom, Relationship be-
tween lipid membrane area, hydrophobic thickness, and
BBAMEM 77405 3-8-98
C. Vermehren et al. / Biochimica et Biophysica Acta 1373 (1998) 27^3634
acyl-chain orientational order. The e¡ects of cholesterol,
Biophys. J. 57 (1990) 405^412.
[6] M. Bloom, E. Evans, O.G. Mouritsen, Physical properties of
the £uid lipid bilayer component of cell membranes: a per-
spective, Q. Rev. Biophys. 24 (1991) 293^397.
[7] D.D. Lasic, D. Needham, The ‘Stealth’ liposome: a proto-
typical biomaterial, Chem. Rev. 95 (1995) 2601^2628.
[8] T.M. Allen, A. Chonn, Large unilamellar liposomes with
low uptake by the reticuloendothelial system, FEBS Lett.
223 (1987) 42^46.
[9] G. Blume, G. Cevc, Liposomes for the sustained drug release
in vivo, Biochim. Biophys. Acta 1029 (1990) 91^97.
[10] D.D. Lasic, F. Martin (Eds.), Stealth Liposomes. CRC
Press, Boca Raton, FL, 1995.
[11] A. Chonn, P.R. Cullis, Recent advances in liposomal drug-
delivery systems, Curr. Opin. Biotechnol. 6 (1995) 698^708.
[12] K. Hristova, D. Needham, The in£uence of polymer-grafted
lipids on the physical properties of lipid bilayers: a theoret-
ical study, J. Colloid Interface Sci. 168 (1994) 302^314.
[13] K. Hristova, D. Needham, Phase behaviour of a lipid/poly-
mer-lipid mixture in aqueous medium, Macromolecules 28
(1995) 991^1002.
[14] K. Hristova, A. Kenworthy, T.J. McIntosh, E¡ect of bilayer
composition on the phase behaviour of liposomal suspen-
sions containing poly(ethylene glycol)-lipids, Macromole-
cules 28 (1995) 7693^7699.
[15] A.K. Kenworthy, S.A. Simon, T.J. McIntosh, Structure and
phase behavior of lipid suspensions containing phospholipids
with covalently attached poly(ethylene glycol), Biophys. J. 68
(1995) 1903^1920.
[16] A.K. Kenworthy, K. Hristova, D. Needham, T.J. McIntosh,
Range and magnitude of the steric pressure between bilayers
containing phospholipids with covalently attached poly(eth-
ylene glycol), Biophys. J. 68 (1995) 1921^1936.
[17] T.R. Baekmark, S. Pedersen, K. JÖrgensen, O.G. Mouritsen,
The e¡ects of ethylene oxide containing lipopolymers and
tri-block copolymers on lipid bilayers of dipalmitoylphos-
phatidylcholine, Biophys. J. 73 (1997) 1479^1491.
[18] G. Blume, G. Cevc, Molecular mechanism of the lipid vesicle
longevity in vivo, Biochim. Biophys. Acta 1146 (1993) 157^
168.
[19] A. Chonn, S.C. Semple, P.R. Cullis, Association of blood
proteins with large unilamellar liposomes in vivo. Relation
to circulation lifetimes, J. Biol. Chem. 267 (1992) 18759^
18765.
[20] D.E. Vance, J. Vance (Eds.), Biochemistry of Lipids, Lipo-
proteins and Membranes, Elsevier, Amsterdam, 1991.
[21] H.S. Hansen, A.M. Vinggard, L. Lauritzen, C. Vermehren,
A.M. Strand, A general view on mammalian phospholipases,
TemaNord 624 (1995) 221^227.
[22] J.P. Wery, W. Schevitz, D.K. Clawson, J.L. Bobbitt, E.R.
Dow, G. Gamboa, T.J.R. Goodson, R.B. Hermann, R.M.
Kramer, E. McClure, D. Mihelich, J.E. Putnam, J.D. Sharp,
J.D. Stark, C. Teater, M.W. Warrick, N.D. Jones, Structure
of recombinant human rheumatoid arthritic synovial £uid
phospholipase A2 at 2.2 resolution, Nature 352 (1991) 79^82.
[23] W.R. Burrack, Q. Yuan, R.L. Biltonen, Role of lateral phase
separation in the modulation of phospholipase A2 activity,
Biochemistry 32 (1993) 583^589.
[24] T. HÖnger, K. JÖrgensen, R.L. Biltonen, O.G. Mouritsen,
Systematic relationship between phospholipase A2 and dy-
namic lipid bilayer microheterogeneity, Biochemistry 35
(1996) 9003^9006.
[25] T. HÖnger, K. JÖrgensen, D. Stokes, R.L. Biltonen, O.G.
Mouritsen, Phospholipase A2 activity and physical proper-
ties of lipid-bilayer substrates, Methods Enzymol. 286 (1997)
168^190.
[26] J.Y.A. Lehtonen, P.K.J. Kinnunen, Phospholipase A2 as a
mechanosensor, Biophys. J. 68 (1995) 1888^1894.
[27] M.J. She⁄eld, B.L. Baker, D. Li, N.L. Owen, M.L. Baker,
J.D. Bell, Enhancement of Agkistrodon piscivorus piscivorus
venom phospholipase A2 activity toward phosphatidylcho-
line vesicle by lysolecithin and palmitic acid: studies with
£uorescent probes of membrane structure, Biochemistry 34
(1995) 7796^7806.
[28] M.J. Hope, M.B. Bally, G. Webb, P.R. Cullis, Production of
large unilamellar vesicles by a rapid extrusion procedure.
Characterization of size distribution, trapped volume and
ability to maintain a membrane potential, Biochem. Biophys.
Acta 812 (1985) 55^65.
[29] J.M. Maraganore, G. Merutka, W. Cho, W. Welches, F.J.
Kezdy, R.L. Heinrikson, A new class of phospholipases A2
with lysine in place of aspartate 49. Functional consequences
for calcium and substrate binding, J. Biol. Chem. 259 (1984)
13839^13843.
[30] M. Wong, T.E. Thompson, Aggregation of dipalmitoylphos-
phatidylcholine vesicles, Biochemistry 21 (1982) 4133^4139.
[31] W.R. Burrack, R.L. Biltonen, Lipid bilayer heterogeneity
and modulation of phospholipase A2 activity, Chem. Phys.
Lipids 73 (1994) 209^222.
[32] J.A.F. Op den Kamp, J. de Gier, L.L.M. van Deenen, Hy-
drolysis of phosphatidyltidylcholine liposomes by pancreatic
phospholipase A2 at the transition temperature, Biochim.
Biophys. Acta 345 (1974) 253^256.
[33] R. Apitz-Castro, M.K. Jain, G.H. De Haas, Origin of the
latency phase during the action of phospholipase A2 on un-
modi¢ed phosphatidyltidylcholine vesicles, Biochim. Bio-
phys. Acta 688 (1982) 349^356.
[34] M. Menashe, G. Romero, R.L. Biltonen, D. Lichtenberg,
Hydrolysis of dipalmitoylphosphatidylcholine large unila-
mellar vesicles by porcine pancreatic phospholipase A2,
J. Biol. Chem. 261 (1986) 5328^5333.
[35] H.E. Warriner, S.H.J. Idziak, N.L. Slack, P. Davidson, C.R.
Sa¢nya, Lamellar biogels: £uid-membrane-based hydrogels
containing polymer lipids, Science 271 (1996) 969^973.
[36] T. Brumm, K. JÖrgensen, O.G. Mouritsen, T.M. Bayerl, The
e¡ect of increasing curvature on the phase transition and
mixing properties of a dimyristoyl-sn-glycero-3-phospha-
tidylcholine/distearoyldimyristoyl-sn-glycero-3-phosphatidyl-
choline lipid mixture as studied by Fourier transform infra-
red spectroscopy and di¡erential scanning calorimetry,
Biophys. J. 70 (1996) 1373^1379.
BBAMEM 77405 3-8-98
C. Vermehren et al. / Biochimica et Biophysica Acta 1373 (1998) 27^36 35
[37] O.G. Mouritsen, K. JÖrgensen, Small-scale lipid structure.
Experiment versus simulation, Curr. Opin. Struct. Biol. 7
(1997) 518^527.
[38] S. Leibler, Curvature instability in membranes, J. Phys.
(Paris) 47 (1986) 507^516.
[39] A.C. Bach, J. Fe¤re¤zou, A. Frey, Phospholipid-rich particles
in commercial parential fat emulsions. An overview, Prog.
Lipid Res. 35 (1996) 133^153.
[40] N. Gheriani-Gruszka, S. Almog, R.L. Biltonen, D. Lichten-
berg, Hydrolysis of phosphatidylcholine in phosphatidylcho-
line-cholate mixtures by porcine pancreatic phospholipase
A2, J. Biol. Chem. 24 (1988) 11808^11813.
[41] M.H. Gelb, M.K. Jain, O.G. Berg, Inhibition of phospho-
lipase A2, FASEB J. 8 (1994) 916^924.
[42] M.K. Jain, O.G. Berg, The kinetics of interfacial catalysis by
phopholipase A2 and regulation of interfacial activation:
hopping versus scooting, Biochim. Biophys. Acta 1002
(1989) 127^156.
[43] K. JÖrgensen, J.H. Ipsen, O.G. Mouritsen, Lipid-bilayer het-
erogeneity, in: E.E. Bittar, N. Bittar (Eds.), Principles of
Medical Biology, Vol. 7A, JAI Press, Connecticut, 1997,
pp. 19^38.
BBAMEM 77405 3-8-98
C. Vermehren et al. / Biochimica et Biophysica Acta 1373 (1998) 27^3636
